Previous 10 | Next 10 |
2024-01-09 14:26:52 ET More on Sanofi Sanofi: Expect A Weak 2024 Leading Up To A Strong 2025 R&D Day Sanofi: A Shift In The Story FDA evaluating reports of GLP-1 drugs and negative side effects Scribe Therapeutics expands collaboration with Sanofi...
2024-01-08 09:45:08 ET SPDR Bloomberg Barclays 1-3 Month T-Bill ETF (BIL) BIL is trading UP for the last 5 days, and it at trading at $91.48 with volume of 1,122,685 and a one day change of $0.01 (0.01%). SPDR Bloomberg Barclays 1-3 Month T-Bill ETF has a 52-week low of 91.21 and a ...
2024-01-05 14:31:55 ET More on AstraZeneca, Eli Lilly, etc. Profiting From Obesity Drugs HRTS, Novo Nordisk And Eli Lilly Why AstraZeneca's Gracell Biotechnologies Acquisition Is A Win-Win Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgra...
2024-01-05 09:07:57 ET More on Big Pharma Bristol-Myers Squibb Company (BMY) Management presents at Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Merck & Co., Inc. (MRK) Goldman Sachs Healthcare C-Suite Unscripted Conference (Transcript) Bri...
2024-01-04 13:51:02 ET More on BioNTech, Moderna, etc. Pfizer: If You Missed The Pandemic Entry, Here's Another Chance BioNTech's Strategic Shift: Diversifying Into Cancer Therapeutics The Pfizer Advantage: High Dividend Yield, JN.1 Variant, And Therapeutic Innovatio...
2024-01-03 07:14:36 ET More on Sanofi Sanofi: Expect A Weak 2024 Leading Up To A Strong 2025 R&D Day Sanofi: A Shift In The Story AstraZeneca, Sanofi RSV infant shot authorized in China Drugmakers reportedly planning to raise prices on 500+ drugs ...
2023-12-29 12:01:36 ET More on Pfizer The Pfizer Advantage: High Dividend Yield, JN.1 Variant, And Therapeutic Innovations Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase Pfizer: Buy The Panic Pfizer in 2024: What to expect? P...
2023-12-28 10:00:00 ET Summary Alpinum Investment Management is a Swiss asset manager whose key areas of expertise include. traditional and alternative credit investments, direct lending and hedge funds. The economy faces a slowdown with rising capital costs, yet resilient consume...
2023-12-27 12:29:36 ET More on AbbVie, Johnson & Johnson, etc. Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) AbbVie Vs. GSK: Dual Dominance In Pharma ...
2023-12-21 12:11:22 ET More on Sanofi Sanofi: Expect A Weak 2024 Leading Up To A Strong 2025 R&D Day Sanofi: A Shift In The Story Innate Pharma jumps 15% on licensing natural killer cell engager with Sanofi EU regulators issue positive opinion on ...
News, Short Squeeze, Breakout and More Instantly...
Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. ...
2024-07-09 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...